Capital Fund Management (CFM)’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.65M | Sell |
|
|||||
|
2025
Q2 | $2.7M | Sell |
|
|||||
|
2025
Q1 | $4.58M | Sell |
|
|||||
|
2024
Q4 | $12.1M | Sell |
|
|||||
|
2024
Q3 | $12.1M | Sell |
|
|||||
|
2024
Q2 | $14.9M | Buy |
|
|||||
|
2024
Q1 | $12.9M | Buy |
|
|||||
|
2023
Q4 | $7.63M | Buy |
|
|||||
|
2023
Q3 | $3.66M | Sell |
|
|||||
|
2023
Q2 | $5.54M | Buy |
|
|||||
|
2023
Q1 | $3.03M | Sell |
|
|||||
|
2022
Q4 | $3.83M | Sell |
|
|||||
|
2022
Q3 | $4.3M | Buy |
|
|||||
|
2022
Q2 | $2.86M | Buy |
|
|||||
|
2022
Q1 | $1.94M | Buy |
|
|||||
|
2021
Q4 | $1.24M | Sell |
|
|||||
|
2021
Q3 | $1.02M | Buy |
|
|||||
|
2021
Q2 | $861K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $559K | Sell |
|
|||||
|
2020
Q2 | $825K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $363K | Sell |
|
|||||
|
2019
Q3 | $321K | Buy |
|